全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prostate-specific antigen testing accuracy in community practice

DOI: 10.1186/1471-2296-3-19

Keywords: Prostatic neoplasms, prostate-specific antigen, sensitivity and specificity, ROC curve, likelihood functions

Full-Text   Cite this paper   Add to My Lib

Abstract:

PSA testing results were compared with a reference standard of prostate biopsy. Subjects were 2,620 men 40 years and older undergoing (PSA) testing and biopsy from 1/1/95 through 12/31/98 in the Albuquerque, New Mexico metropolitan area. Diagnostic measures included the area under the receiver-operating characteristic curve, sensitivity, specificity, and likelihood ratios.Cancer was detected in 930 subjects (35%). The area under the ROC curve was 0.67 and the PSA cutpoint of 4 ng/ml had a sensitivity of 86% and a specificity of 33%. The likelihood ratio for a positive test (LR+) was 1.28 and 0.42 for a negative test (LR-). PSA testing was most sensitive (90%) but least specific (27%) in older men. Age-specific reference ranges improved specificity in older men (49%) but decreased sensitivity (70%), with an LR+ of 1.38. Lowering the PSA cutpoint to 2 ng/ml resulted in a sensitivity of 95%, a specificity of 20%, and an LR+ of 1.19.PSA testing had fair discriminating power for detecting prostate cancer in community practice. The PSA cutpoint of 4 ng/ml was sensitive but relatively non-specific and associated likelihood ratios only moderately revised probabilities for cancer. Using age-specific reference ranges and a PSA cutpoint below 4 ng/ml improved test specificity and sensitivity, respectively, but did not improve the overall accuracy of PSA testing.Prostate cancer is the most frequently diagnosed visceral cancer in the United States and the second leading cause of cancer death in men [1]. Unfortunately, there are no proven primary prevention strategies for prostate cancer and no curative treatments for distant-stage cancers [2,3]. Consequently, cancer control efforts have focused on detecting early-stage prostate cancer with screening tests and then aggressively treating the cancer with surgery or radiation. The most effective screening test is the prostate-specific antigen (PSA) assay, which in combination with digital rectal examination (DRE) substantially enhan

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133